封面
市場調查報告書
商品編碼
1991477

2026-2034年全球眼眶成形術市場規模、佔有率、趨勢和成長分析報告

Global Kyphoplasty Market Size, Share, Trends & Growth Analysis Report 2026-2034

出版日期: | 出版商: Value Market Research | 英文 172 Pages | 商品交期: 最快1-2個工作天內

價格
簡介目錄

預計到 2034 年,後凸成形術市場規模將達到 1,298,760,000 美元,高於 2025 年的 775,950,000 美元,預計從 2026 年到 2034 年的複合年成長率將達到 5.89%。

由於脊椎骨折和骨質疏鬆相關疾病病例的增加,全球後凸成形術市場正在擴張。後凸成形術是一種微創手術,透過使用特殊的骨水泥固定受損脊椎骨來治療椎體壓迫性骨折。此手術有助於緩解疼痛、恢復脊椎排列並改善患者的活動能力。

市場成長主要受全球人口老化和骨質疏鬆症盛行率上升的驅動。老年人更容易發生脊椎骨折,因此對有效治療方法的需求日益成長。影像學和外科技術的進步正在提高後凸成形術的安全性和有效性。

隨著醫療專業人員不斷採用低侵襲性脊椎治療,後凸成形術市場前景光明。持續的研發投入旨在改善手術器械和材料,可望提升治療效果。此外,發展中國家整形外科服務的普及化預計也將促進市場成長。隨著脊椎健康在老化社會中日益受到重視,後凸成形術術的數量預計將會增加。

目錄

第1章:引言

第2章執行摘要

第3章 市場變數、趨勢與框架

  • 市場譜系展望
  • 滲透率和成長前景分析
  • 價值鏈分析
  • 法律規範
    • 標準與合規性
    • 監管影響分析
  • 市場動態
    • 市場促進因素
    • 市場限制因素
    • 市場機遇
    • 市場挑戰
  • 波特五力分析
  • PESTLE分析

第4章 全球眼球成形術市場:依產品分類

  • 市場分析、洞察與預測
  • 球囊導管
  • 骨科入路裝置
  • 骨水泥
  • 水泥攪拌系統
  • 裝置

第5章:全球塑膠市場:依應用領域分類

  • 市場分析、洞察與預測
  • 恢復脊椎排列
  • 椎體骨折
  • 脊柱後凸

第6章 全球眼球成形術市場:依適應症分類

  • 市場分析、洞察與預測
  • 骨質疏鬆症
  • 其他

第7章 全球眼眶成形術市場:依最終用途分類

  • 市場分析、洞察與預測
  • 醫院和診所
  • 門診手術中心
  • 其他

第8章 全球眼眶成形術市場:依地區分類

  • 區域分析
  • 北美市場分析、洞察與預測
    • 美國
    • 加拿大
    • 墨西哥
  • 歐洲市場分析、洞察與預測
    • 英國
    • 法國
    • 德國
    • 義大利
    • 俄羅斯
    • 其他歐洲國家
  • 亞太市場分析、洞察與預測
    • 印度
    • 日本
    • 韓國
    • 澳洲
    • 東南亞
    • 其他亞太國家
  • 拉丁美洲市場分析、洞察與預測
    • 巴西
    • 阿根廷
    • 秘魯
    • 智利
    • 其他拉丁美洲國家
  • 中東和非洲市場分析、洞察與預測
    • 沙烏地阿拉伯
    • UAE
    • 以色列
    • 南非
    • 其他中東和非洲國家

第9章 競爭情勢

  • 最新趨勢
  • 公司分類
  • 供應鏈和銷售管道合作夥伴(根據現有資訊)
  • 市場佔有率和市場定位分析(基於現有資訊)
  • 供應商情況(基於現有資訊)
  • 策略規劃

第10章:公司簡介

  • 主要公司的市佔率分析
  • 公司簡介
    • Stryker
    • MicroPort Scientific Corporation
    • Medtronic Inc
    • DePuy Synthes(Johnson & Johnson Services Inc.)
    • Smith & Nephew
    • IZI Medical Products
    • Merit Medical Systems
    • CareFusion
    • Joimax GmbH
    • Joline GmbH & Co. KG
    • G21 Srl
    • IMEDICOM
    • Seawon MeditechTaeyeon Medical Co. Ltd
    • Hensler Surgical Products
    • Jiangsu ChangMei Medtech Co. Ltd
簡介目錄
Product Code: VMR11214140

The Kyphoplasty Market size is expected to reach USD 1298.76 Million in 2034 from USD 775.95 Million (2025) growing at a CAGR of 5.89% during 2026-2034.

The global kyphoplasty market has grown due to increasing cases of spinal fractures and osteoporosis-related conditions. Kyphoplasty is a minimally invasive surgical procedure used to treat vertebral compression fractures by stabilizing the affected vertebrae with specialized bone cement. This procedure helps relieve pain, restore spinal alignment, and improve patient mobility.

Market growth is driven by the aging global population and the rising prevalence of osteoporosis. Older adults are more likely to experience spinal fractures, creating a need for effective treatment options. Advances in imaging technologies and surgical techniques have improved the safety and effectiveness of kyphoplasty procedures.

The future of the kyphoplasty market appears promising as healthcare providers continue to adopt minimally invasive spine treatments. Ongoing research into improved surgical tools and materials may enhance treatment outcomes. Expanding access to specialized orthopedic care in developing regions is also expected to support market growth. As spinal health becomes an important focus in aging populations, kyphoplasty procedures are likely to increase.

MARKET SEGMENTATION

By Product

  • Balloon Catheters
  • Bone Access Devices
  • Bone Cement
  • Cement Mixing Systems
  • Instruments

By Application

  • Vertebral Alignment Restoration
  • Spinal Fractures
  • Kyphosis

By Indication

  • Osteoporosis
  • Others

By End-Use

  • Hospitals & Clinics
  • Ambulatory Surgical Centers
  • Others

COMPANIES PROFILED

  • Stryker, MicroPort Scientific Corporation, Medtronic Inc, DePuy Synthes Johnson Johnson Services Inc, Smith Nephew, IZI Medical Products, Merit Medical Systems, CareFusion, Joimax GmbH, Joline GmbH Co KG, G21 Srl, iMEDICOM, Seawon MeditechTaeyeon Medical Co Ltd, Hensler Surgical Products, Jiangsu ChangMei Medtech Co Ltd
  • We can customise the report as per your requirements.

TABLE OF CONTENTS

Chapter 1. PREFACE

  • 1.1. Market Segmentation & Scope
  • 1.2. Market Definition
  • 1.3. Information Procurement
    • 1.3.1 Information Analysis
    • 1.3.2 Market Formulation & Data Visualization
    • 1.3.3 Data Validation & Publishing
  • 1.4. Research Scope and Assumptions
    • 1.4.1 List of Data Sources

Chapter 2. EXECUTIVE SUMMARY

  • 2.1. Market Snapshot
  • 2.2. Segmental Outlook
  • 2.3. Competitive Outlook

Chapter 3. MARKET VARIABLES, TRENDS, FRAMEWORK

  • 3.1. Market Lineage Outlook
  • 3.2. Penetration & Growth Prospect Mapping
  • 3.3. Value Chain Analysis
  • 3.4. Regulatory Framework
    • 3.4.1 Standards & Compliance
    • 3.4.2 Regulatory Impact Analysis
  • 3.5. Market Dynamics
    • 3.5.1 Market Drivers
    • 3.5.2 Market Restraints
    • 3.5.3 Market Opportunities
    • 3.5.4 Market Challenges
  • 3.6. Porter's Five Forces Analysis
  • 3.7. PESTLE Analysis

Chapter 4. GLOBAL KYPHOPLASTY MARKET: BY PRODUCT 2022-2034 (USD MN)

  • 4.1. Market Analysis, Insights and Forecast Product
  • 4.2. Balloon Catheters Estimates and Forecasts By Regions 2022-2034 (USD MN)
  • 4.3. Bone Access Devices Estimates and Forecasts By Regions 2022-2034 (USD MN)
  • 4.4. Bone Cement Estimates and Forecasts By Regions 2022-2034 (USD MN)
  • 4.5. Cement Mixing Systems Estimates and Forecasts By Regions 2022-2034 (USD MN)
  • 4.6. Instruments Estimates and Forecasts By Regions 2022-2034 (USD MN)

Chapter 5. GLOBAL KYPHOPLASTY MARKET: BY APPLICATION 2022-2034 (USD MN)

  • 5.1. Market Analysis, Insights and Forecast Application
  • 5.2. Vertebral Alignment Restoration Estimates and Forecasts By Regions 2022-2034 (USD MN)
  • 5.3. Spinal Fractures Estimates and Forecasts By Regions 2022-2034 (USD MN)
  • 5.4. Kyphosis Estimates and Forecasts By Regions 2022-2034 (USD MN)

Chapter 6. GLOBAL KYPHOPLASTY MARKET: BY INDICATION 2022-2034 (USD MN)

  • 6.1. Market Analysis, Insights and Forecast Indication
  • 6.2. Osteoporosis Estimates and Forecasts By Regions 2022-2034 (USD MN)
  • 6.3. Others Estimates and Forecasts By Regions 2022-2034 (USD MN)

Chapter 7. GLOBAL KYPHOPLASTY MARKET: BY END-USE 2022-2034 (USD MN)

  • 7.1. Market Analysis, Insights and Forecast End-use
  • 7.2. Hospitals & Clinics Estimates and Forecasts By Regions 2022-2034 (USD MN)
  • 7.3. Ambulatory Surgical Centers Estimates and Forecasts By Regions 2022-2034 (USD MN)
  • 7.4. Others Estimates and Forecasts By Regions 2022-2034 (USD MN)

Chapter 8. GLOBAL KYPHOPLASTY MARKET: BY REGION 2022-2034 (USD MN)

  • 8.1. Regional Outlook
  • 8.2. North America Market Analysis, Insights and Forecast, 2022-2034 (USD MN)
    • 8.2.1 By Product
    • 8.2.2 By Application
    • 8.2.3 By Indication
    • 8.2.4 By End-use
    • 8.2.5 United States
    • 8.2.6 Canada
    • 8.2.7 Mexico
  • 8.3. Europe Market Analysis, Insights and Forecast, 2022-2034 (USD MN)
    • 8.3.1 By Product
    • 8.3.2 By Application
    • 8.3.3 By Indication
    • 8.3.4 By End-use
    • 8.3.5 United Kingdom
    • 8.3.6 France
    • 8.3.7 Germany
    • 8.3.8 Italy
    • 8.3.9 Russia
    • 8.3.10 Rest Of Europe
  • 8.4. Asia-Pacific Market Analysis, Insights and Forecast, 2022-2034 (USD MN)
    • 8.4.1 By Product
    • 8.4.2 By Application
    • 8.4.3 By Indication
    • 8.4.4 By End-use
    • 8.4.5 India
    • 8.4.6 Japan
    • 8.4.7 South Korea
    • 8.4.8 Australia
    • 8.4.9 South East Asia
    • 8.4.10 Rest Of Asia Pacific
  • 8.5. Latin America Market Analysis, Insights and Forecast, 2022-2034 (USD MN)
    • 8.5.1 By Product
    • 8.5.2 By Application
    • 8.5.3 By Indication
    • 8.5.4 By End-use
    • 8.5.5 Brazil
    • 8.5.6 Argentina
    • 8.5.7 Peru
    • 8.5.8 Chile
    • 8.5.9 Rest of Latin America
  • 8.6. Middle East & Africa Market Analysis, Insights and Forecast, 2022-2034 (USD MN)
    • 8.6.1 By Product
    • 8.6.2 By Application
    • 8.6.3 By Indication
    • 8.6.4 By End-use
    • 8.6.5 Saudi Arabia
    • 8.6.6 UAE
    • 8.6.7 Israel
    • 8.6.8 South Africa
    • 8.6.9 Rest of the Middle East And Africa

Chapter 9. COMPETITIVE LANDSCAPE

  • 9.1. Recent Developments
  • 9.2. Company Categorization
  • 9.3. Supply Chain & Channel Partners (based on availability)
  • 9.4. Market Share & Positioning Analysis (based on availability)
  • 9.5. Vendor Landscape (based on availability)
  • 9.6. Strategy Mapping

Chapter 10. COMPANY PROFILES OF GLOBAL KYPHOPLASTY INDUSTRY

  • 10.1. Top Companies Market Share Analysis
  • 10.2. Company Profiles
    • 10.2.1 Stryker
    • 10.2.2 MicroPort Scientific Corporation
    • 10.2.3 Medtronic Inc
    • 10.2.4 DePuy Synthes (Johnson & Johnson Services Inc.)
    • 10.2.5 Smith & Nephew
    • 10.2.6 IZI Medical Products
    • 10.2.7 Merit Medical Systems
    • 10.2.8 CareFusion
    • 10.2.9 Joimax GmbH
    • 10.2.10 Joline GmbH & Co. KG
    • 10.2.11 G21 S.r.l
    • 10.2.12 IMEDICOM
    • 10.2.13 Seawon MeditechTaeyeon Medical Co. Ltd
    • 10.2.14 Hensler Surgical Products
    • 10.2.15 Jiangsu ChangMei Medtech Co. Ltd